Eyepoint Pharmaceuticals Inc (EYPT) — Capital Reinvestment Ratio
Eyepoint Pharmaceuticals Inc (EYPT) has a Capital Reinvestment Ratio of 0.01x as of June 2023, meaning it reinvests 0% of its operating cash flow ($57.02 Million) in capital expenditures ($396.00K). See debt-free asset ratio of Eyepoint Pharmaceuticals Inc to measure how much of total assets are equity-financed.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Eyepoint Pharmaceuticals Inc Capital Reinvestment Ratio (2010–2023)
This chart tracks Eyepoint Pharmaceuticals Inc's Capital Reinvestment Ratio across 3 annual periods. Check Eyepoint Pharmaceuticals Inc cash flow reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.
Annual Capital Reinvestment Ratio for Eyepoint Pharmaceuticals Inc (2010–2023)
Year-by-year Capital Reinvestment Ratio for Eyepoint Pharmaceuticals Inc from 2010 to 2023. For live market cap and broader valuation context, see Eyepoint Pharmaceuticals Inc (EYPT) market capitalisation.
| Year | Reinvestment Ratio | Operating CF (USD) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2023 | 1.86x | $1.88 Million | $3.48 Million | ▲ +11780.6% |
| 2015 | 0.02x | $10.30 Million | $161.00K | ▲ +931.8% |
| 2010 | 0.00x | $9.90 Million | $15.00K | — |